213Bi-DOTATOC receptor-targeted alph-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience
Journal Article
·
· European Journal of Nuclear Medicine
OSTI ID:1158757
- ORNL
- Heidelberg University, Germany
- University of Heidelberg
- European Commission Joint Research Centre
- Research Organization:
- Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- DE-AC05-00OR22725
- OSTI ID:
- 1158757
- Journal Information:
- European Journal of Nuclear Medicine, Journal Name: European Journal of Nuclear Medicine
- Country of Publication:
- United States
- Language:
- English
Similar Records
Contribution of {sup 68}Ga-DOTATOC PET/CT to Target Volume Delineation of Skull Base Meningiomas Treated With Stereotactic Radiation Therapy
Improved safety and efficacy of 213Bi-DOTATATE-targeted alpha therapy of somatostatin receptor-expressing neuroendocrine tumors in mice pre-treated with l-lysine
18F-FDOPA PET/CT-Guided Radiofrequency Ablation of Liver Metastases from Neuroendocrine Tumours: Technical Note on a Preliminary Experience
Journal Article
·
Tue Jan 01 00:00:00 EST 2013
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:1158757
+7 more
Improved safety and efficacy of 213Bi-DOTATATE-targeted alpha therapy of somatostatin receptor-expressing neuroendocrine tumors in mice pre-treated with l-lysine
Journal Article
·
Mon Nov 21 00:00:00 EST 2016
· EJNMMI Research
·
OSTI ID:1158757
+7 more
18F-FDOPA PET/CT-Guided Radiofrequency Ablation of Liver Metastases from Neuroendocrine Tumours: Technical Note on a Preliminary Experience
Journal Article
·
Thu Sep 15 00:00:00 EDT 2016
· Cardiovascular and Interventional Radiology
·
OSTI ID:1158757
+6 more